4.7 Article

Species-Specific Identification of a Wide Range of Clinically Relevant Fungal Pathogens by Use of Luminex xMAP Technology

期刊

JOURNAL OF CLINICAL MICROBIOLOGY
卷 47, 期 4, 页码 1063-1073

出版社

AMER SOC MICROBIOLOGY
DOI: 10.1128/JCM.01558-08

关键词

-

资金

  1. Austrian Science Fund (FWF) [P16929-B13]
  2. Austrian Center for Innovation and Technology (ZIT)
  3. Fonds der Stadt Wien fur innovative interdisziplinare Krebsforschung
  4. Austrian Science Fund (FWF) [P16929] Funding Source: Austrian Science Fund (FWF)

向作者/读者索取更多资源

In immunocompromised patients suffering from invasive fungal infection, rapid identification of the fungal species is a prerequisite for selection of the most appropriate antifungal treatment. We present an assay permitting reliable identification of a wide range of clinically relevant fungal pathogens based on the high-throughput Luminex microbead hybridization technology. The internal transcribed spacer (ITS2) region, which is highly variable among genomes of individual fungal species, was used to generate oligonucleotide hybridization probes for specific identification. The spectrum of pathogenic fungi covered by the assay includes the most commonly occurring species of the genera Aspergillus and Candida and a number of important emerging fungi, such as Cryptococcus, Fusarium, Trichosporon, Mucor, Rhizopus, Penicillium, Absidia, and Acremonium. Up to three different probes are employed for the detection of each fungal species. The redundancy in the design of the assay should ensure unambiguous fungus identification even in the presence of mutations in individual target regions. The current set of hybridization oligonucleotides includes 75 species-and genus-specific probes which had been carefully tested for specificity by repeated analysis of multiple reference strains. To provide adequate sensitivity for clinical application, the assay includes amplification of the ITS2 region by a seminested PCR approach prior to hybridization of the amplicons to the probe panel using the Luminex technology. A variety of fungal pathogens were successfully identified in clinical specimens that included peripheral blood, samples from biopsies of pulmonary infiltrations, and bronchotracheal secretions derived from patients with documented invasive fungal infections. Our observations demonstrate that the Luminex-based technology presented permits rapid and reliable identification of fungal species and may therefore be instrumental in routine clinical diagnostics.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.7
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Oncology

A kinase profile-adapted drug combination elicits synergistic cooperative effects on leukemic cells carrying BCR-ABL1T315I in Ph+ CML

Karoline V. Gleixner, Irina Sadovnik, Mathias Schneeweiss, Gregor Eisenwort, Konstantin Byrgazov, Gabriele Stefanzl, Daniela Berger, Harald Herrmann, Emir Hadzijusufovic, Thomas Lion, Peter Valent

LEUKEMIA RESEARCH (2019)

Article Oncology

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph plus ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1

H. Pfeifer, G. Cazzaniga, V. H. J. van der Velden, J. M. Cayuele, B. Schafer, O. Spinelli, S. Akiki, S. Avigad, I Bendit, K. Borg, H. Cave, L. Elia, S. C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M. C. Chillon, C. Homburg, G. Martinelli, V Kairisto, T. Langen, T. Lion, M. C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Server, E. Herrmann, S. Markovic, J. J. M. van Dongen, O. G. Ottmann

LEUKEMIA (2019)

Article Microbiology

Diagnostic Parameters of Adenoviremia in Pediatric Stem Cell Transplant Recipients

Karin Kosulin, Herbert Pichler, Anita Lawitschka, Rene Geyeregger, Thomas Lion

FRONTIERS IN MICROBIOLOGY (2019)

Review Hematology

Proposed diagnostic criteria for classical chronic myelomonocytic leukemia (CMML), CMML variants and pre-CMML conditions

Peter Valent, Attilio Orazi, Michael R. Savona, Mrinal M. Patnaik, Francesco Onida, Arjan A. van de Loosdrecht, Detlef Haase, Torsten Haferlach, Chiara Elena, Lisa Pleyer, Wolfgang Kern, Tea Pemovska, Gregory Vladimer, Julie Schanz, Alexandra Keller, Michael Luebbert, Thomas Lion, Karl Sotlar, Andreas Reiter, Theo De Witte, Michael Pfeilstoecker, Klaus Geissler, Eric Padron, Michael Deininger, Alberto Orfao, Hans-Peter Horny, Peter L. Greenberg, Daniel A. Arber, Luca Malcovati, John M. Bennett

HAEMATOLOGICA (2019)

Review Oncology

Treatment and monitoring of Philadelphia chromosome-positive leukemia patients: recent advances and remaining challenges

Simona Soverini, Renato Bassan, Thomas Lion

JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)

Letter Oncology

In Ph+BCR-ABL1P210+ acute lymphoblastic leukemia the e13a2 (B2A2) transcript is prevalent

Michele Baccarani, Ilaria Iacobucci, Sabina Chiaretti, Robin Foa', Poonkuzhali Balasubramanian, Elisabeth Paietta, Letizia Foroni, Sabine Jeromin, Barbara Izzo, Orietta Spinelli, Neelam Varma, Samia Menif, Carolina Terragna, Tulika Seth, Audrey Bidet, Daniel Coriu, Francesca Lunghi, Jiri Mayer, Barbara Scappini, Stephen Langabeer, Jacqueline Maier, Emma Burt, Anna Candoni, Francesco Albano, Mario Luppi, Irena Zupan, Thomas Lion, Renata Zadro, Francesco di Raimondo, Behzad Poopak, Giovanna Rege-Cambrin, Mario Annunziata, Ana Ayala, Victor Salinas-Viedma, Ana Ines Pado, Benedict Milner, Sara Galimberti, Jeroen Janssen, Valentina Polli, Lorenzo Comba, Beatrice Borsellino, Ombretta Annibali, Monica Crugnola, Francesco Passamonti

LEUKEMIA (2020)

Review Microbiology

Pathogenetic Impact of Bacterial-Fungal Interactions

Filomena Nogueira, Shirin Sharghi, Karl Kuchler, Thomas Lion

MICROORGANISMS (2019)

Article Hematology

Detection and Monitoring of Lineage-Specific Chimerism by Digital Droplet PCR-Based Testing of Deletion/Insertion Polymorphisms

Michaela Fortschegger, Sandra Preuner, Dieter Printz, Anna R. Poetsch, Rene Geyeregger, Herbert Pichler, Anita Lawitschka, Thomas Lion

BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2020)

Correction Oncology

Standardisation and consensus guidelines for minimal residual disease assessment in Philadelphia-positive acute lymphoblastic leukemia (Ph+ALL) by real-time quantitative reverse transcriptase PCR of e1a2 BCR-ABL1 (vol 32, pg 345, 2019)

H. Pfeifer, G. Cazzaniga, V. H. J. van der Velden, J. M. Cayuela, B. Schafer, O. Spinelli, S. Akiki, S. Avigad, I. Bendit, K. Borg, H. Cave, L. Elia, S. C. Reshmi, G. Gerrard, S. Hayette, M. Hermanson, A. Juh, T. Jurcek, M. C. Chillon, C. Homburg, G. Martinelli, V. Kairisto, T. Lange, T. Lion, M. C. Mueller, F. Pane, L. Rai, C. Damm-Welk, T. Sacha, S. Schnittger, T. Touloumenidou, H. Valerhaugen, P. Vandenberghe, J. Zuna, H. Serve, E. Herrmann, S. Markovic, J. J. M. van Dongen, O. G. Ottmann

LEUKEMIA (2020)

Article Medicine, General & Internal

CDK4/CDK6 inhibition as a novel strategy to suppress the growth and survival of BCR-ABL1T3151+ clones in TKI-resistant CML

Mathias Schneeweiss-Gleixner, Konstantin Byrgazov, Gabriele Stefanzl, Daniela Berger, Gregor Eisenwort, Chantal Blanche Lucini, Susanne Herndlhofer, Sandra Preuner, Klara Obrova, Petra Pusic, Nadine Witzeneder, Georg Greiner, Gregor Hoermann, Wolfgang R. Sperr, Thomas Lion, Michael Deininger, Peter Valent, Karoline V. Gleixnera

EBIOMEDICINE (2019)

Article Allergy

Transfer and loss of allergen-specific responses via stem cell transplantation: A prospective observational study

Markus Debiasi, Herbert Pichler, Florian Klinglmuller, Heidrun Boztug, Klara Schmidthaler, Jonas Rech, David Scherer, Christian Lupinek, Rudolf Valenta, Ewa Kacinska-Pfaller, Rene Geyeregger, Gerhard Fritsch, Oskar A. Haas, Christina Peters, Thomas Lion, Mubeccel Akdis, Susanne Matthes, Cezmi A. Akdis, Zsolt Szepfalusi, Thomas Eiwegger

ALLERGY (2020)

Article Oncology

Illuminating novel biological aspects and potential new therapeutic approaches for chronic myeloproliferative malignancies

Tariq I. Mughal, Naveen Pemmaraju, Bethan Psaila, Jerald Radich, Prithviraj Bose, Thomas Lion, Jean-Jacques Kiladjian, Raajit Rampal, Tania Jain, Srdnan Verstovsek, Abdulraheem Yacoub, Jorge E. Cortes, Ruben Mesa, Giuseppe Saglio, Richard A. van Etten

HEMATOLOGICAL ONCOLOGY (2020)

Article Oncology

A phase 1 study to evaluate the feasibility and efficacy of the addition of ropeginterferon alpha-2b to imatinib treatment in patients with chronic phase chronic myeloid leukemia (CML) not achieving a deep molecular response (molecular remission 4.5)-AGMT_CML 1

Sonja Heibl, Veronika Buxhofer-Ausch, Stefan Schmidt, Gerald Webersinke, Thomas Lion, Gudrun Piringer, Thomas Kuehr, Dominik Wolf, Thomas Melchardt, Richard Greil, Josef Thaler

HEMATOLOGICAL ONCOLOGY (2020)

Article Oncology

Ponatinib and palbociclib combination in TKI-resistant CML-A case report

Johannes B. Jaeger, Thomas Jaeger, Sandra Preuner, Petra Pusic, Isabella Sponseiler, Thomas Lion, Thomas Winder, Bernd Lorenz Hartmann

Summary: This case study presents a 68-year-old woman with resistance to second- and third-generation TKI therapy due to BCR-ABL1(T315I) and BCR-ABL1(E255V) mutations. An individualized treatment approach using the third-generation TKI ponatinib in combination with palbociclib showed strong antineoplastic effects in this patient resistant to ponatinib monotherapy. Further characterization of the biological activity of this combination treatment is needed in prospective clinical trials.

MEMO-MAGAZINE OF EUROPEAN MEDICAL ONCOLOGY (2021)

Letter Hematology

Combinatorial treatment options for highly resistant compound mutations in the kinase domain of the BCR::ABL1 fusion gene in Ph-positive leukemias

Isabella Sponseiler, Anna-Maria Bandian, Petra Pusic, Thomas Lion

AMERICAN JOURNAL OF HEMATOLOGY (2023)

暂无数据